Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively
仅供研究使用。 我们不向患者出售。
化学信息
名称 | Cabozantinib |
分子式 | C28H24FN3O5 |
分子量 | 501.51 |
Smile | COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F |
InChiKey | ONIQOQHATWINJY-UHFFFAOYSA-N |
InChi | InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
Cas号 | 849217-68-1 |
MDL | MFCD20926324 |
相关CAS号 | |
纯度 | 98% |
可溶性 | DMSO ��114mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL |
处理方式 | |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |